Table 2 Cardiovascular status and long-term clinical outcomes
References | NLR groups | Multi-vessel | Death | MACE |
|---|---|---|---|---|
Shen et al. [12] | ≤ 3.45 | 70.8 | 5.8 | |
3.45–4.81 | 61.5 | 8 | ||
4.82–6.46 | 65.7 | 8.7 | ||
> 6.46 | 76.9 | 26.8 | ||
Han et al. [13] | ≤ 3.3 | – | 2.8 | 3.7 |
3.3–6.5 | 10.2 | 11.1 | ||
> 6.5 | 18.2 | 19.1 | ||
Kaya et al. [14] | < 2.3 | 33 | 8 | 13 |
2.3–4.4 | 44 | 10 | 21 | |
> 4.4 | 48 | 18 | 40 | |
Sen et al. [15] | < 3.3 | 26.4 | 9 | 21 |
3.3–4.5 | 29.4 | 15 | 34 | |
> 4.5 | 32.3 | 35 | 50 | |
Arbel et al. [16] | < 6.5 | 56 | 4.5 | 8.7 |
≥ 6.5 | 49 | 12.9 | 21.1 | |
Ergelen et al. [17] | ≤ 6.97 | 56.8 | 4.8 | 23.7 |
> 6.97 | 58.2 | 7 | 27.4 | |
Pan et al. [18] | 3 | 73.1 | 3.3 | 17.5 |
3.0–6.4 | 78.8 | 5.7 | 19.2 | |
> 6.4 | 76.4 | 11 | 26.9 | |
Zhou et al. [19] | < 2.2 | 63.5 | 2.5 | 13.1 |
2.2–3.8 | 70.9 | 4.2 | 21.1 | |
> 3.8 | 73.5 | 8.2 | 44.5 | |
Wada et al. [20] | < 1.7 | 56.4 | 5.3 | |
1.7–2.5 | 63.3 | 6.3 | ||
> 2.5 | 61.8 | 8.8 | ||
Zuin et al. [21] | < 2.5 | 16 | 0.8 | |
2.5–5.0 | 14.9 | 1.4 | ||
> 5.0 | 14.4 | 7.5 | ||
Xu et al. [22] | ≤ 3.3 | – | 0.8 | 12.6 |
> 3.3 | 5.1 | 21.7 | ||
Choi et al. [23] | ≤ 2.8 | 33.6 | 2.7 | 3.8 |
> 2.8 | 42.7 | 8.7 | 10.4 | |
48.1 | ||||
Liu et al. [24] | < 1.36 | 62.3 | 3 | 11.8 |
1.36–1.96 | 62.6 | 3.3 | 10.2 | |
> 1.96 | 65.3 | 4.5 | 11.2 | |
Gu et al. [25] | ≤ 3.3 | 46.5 | 3.3 | 11.1 |
> 3.3 | 47.2 | 9.2 | 28.9 |